Get started
Author

Yue Zhong

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
2025 · Milind Y. Desai, Anjali T. Owens, et al. · New England Journal of Medicine · 80
PDF
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
2025 · Milind Y. Desai, Steve E. Nissen, et al. · JACC Heart Failure · 34
Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany
2022 · M Schultze, C Zema, et al. · European Heart Journal · 22
Roles of Nitric Oxide and Brassinosteroid in Improving Fruit Quality during Postharvest: Potential Regulators?
2024 · Lijuan Wei, Yue Zhong, et al. · Journal of Agricultural and Food Chemistry · 21
Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
2024 · Milind Y. Desai, Anjali Owens, et al. · Journal of the American College of Cardiology · 14
The Kansas City Cardiomyopathy Questionnaire in Relation to New York Heart Association Class
2024 · CHARLES F. SHERROD, JOHN A. SPERTUS, et al. · Journal of Cardiac Failure · 12
PDF
Effect of Mavacamten on Echocardiographic Features in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Results from the EXPLORER-CN Study
2025 · Zhuang Tian, Xiaoyan Li, et al. · Cardiology and Therapy · 9
PDF
The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Hypertrophic Cardiomyopathy
2024 · ANDREW J. SAUER, CHARLES F. SHERROD, et al. · Journal of Cardiac Failure · 8
PDF
Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan
2023 · Isao Kamae, Yue Zhong, et al. · Journal of Medical Economics · 6
PDF
Genome-Wide Association Studies Using 3VmrMLM Model Provide New Insights into Branched-Chain Amino Acid Contents in Rice Grains
2023 · Yao Sui, Yanru Che, et al. · Plants · 5
PDF
The Experiences, Values and Goals of Patients in Australia Living With Obstructive Hypertrophic Cardiomyopathy: In-depth Patient Interviews
2024 · Simon Fifer, Annmarie Pendleton, et al. · Journal of the American College of Cardiology · 3
Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies
2024 · Vivek Reddy, Yue Zhong, et al. · ClinicoEconomics and Outcomes Research · 3
PDF
Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States
2023 · Stephen J. Greene, John A. Spertus, et al. · Circulation Heart Failure · 3
PDF
Real-world health status changes with mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) - Early findings from COMPASS-HCM
2025 · A Wang, X Han, et al. · European Heart Journal · 1
PDF
Integrated efficacy and safety analysis of mavacamten monotherapy in patients with obstructive hypertrophic cardiomyopathy
2025 · I Olivotto, P Garcia-Pavia, et al. · European Heart Journal · 1
PDF
Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany
2025 · Farbod Sedaghat-Hamedani, Carla L. Zema, et al. · Clinical Research in Cardiology · 1
PDF
Rare complex recurrent cystic echinococcosis with multi-organ involvement after inadequate postoperative therapy: a case report
2025 · Yue Zhong, You Yuan, et al. · Frontiers in Medicine · 1
PDF
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review
2025 · Olivia M. Dong, Na’ngono Manga, et al. · Journal of Medical Economics · 1
PDF
Knowledge, Attitudes, and Practices (KAP) Regarding Complications of High Myopia Among Patients with High Myopia
2026 · Caili Yuan, Caifeng Lei, et al. · Ophthalmic Epidemiology
Abstract 4359841: Patient-Reported Outcomes in Patients with Symptomatic, Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten: Real-world Observations through Week 30 from the COMPASS-HCM Study
2025 · Andrew Wang, Eileen Han, et al. · Circulation
Validation of the Hypertrophic Cardiomyopathy Symptom Questionnaire (hcmsq) 7-day Recall
2025 · Julia Price, Yue Zhong, et al. · Journal of the American College of Cardiology
MSR120 Quantifying Health Related Quality of Life Benefits From Patients Treated With Mavacamten for Obstructive Hypertrophic Cardiomyopathy (HCM) in China Based on the EXPLORER-CN Trial
2024 · Z Cheah, C Simons, et al. · Value in Health
PDF
Abstract 4140118: Identification of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy Patients Using Natural Language Processing in a Large Integrated Healthcare System
2024 · Ann Sheridan, Jane Liu, et al. · Circulation
Clinical characteristics and burden of non-obstructive hypertrophic cardiomyopathy: a real-world survey in Italy and Spain
2024 · M Lowe, J Jackson, et al. · European Heart Journal
Abstract 12019: The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Hypertrophic Cardiomyopathy
2023 · Andrew J Sauer, Charles F Sherrod, et al. · Circulation
Works count: 36
Citation count: 224
H-index: 8
I10-index: 6
Year
Topic
Type